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Abstract


	The thesis has been divided into three chapters.

CHAPTER  I	:	Synthesis of novel β-D-lactopyranosyloxy- and β-D-
maltopyranosyloxy methyl pyrimidines and purines.


	Section  A	:	Synthesis of novel β-D-lactopyranosyloxy methyl 
pyrimidines and purines.



	Section B	:	Synthesis of novel β-D-maltopyranosyloxy methyl 
pyrimidines and purines.



CHAPTER II 	:	Resolution of 1-arylalkylamines with hydrogen
phthalate esters of β-D-glucofuranose bearing 1,2:5,6-di-O-isopropylidene, 1,2:5,6-di-O-cyclohexylidene and 1,2-O-cyclohexylidene-5,6-O-diphenylmethylidene substituents.
 


CHAPTER III	:	Synthesis and resolution of (R,S)-4-methoxy 
amphetamine, an intermediate for the synthesis of (R,R)-Formoterol. 





Chapter I
Section A :	Synthesis of novel β–D-lactopyranosyloxy methyl pyrimidines and purines
	Nucleosides and their analogs have been used over 40 years as cancer and viral therapeutics. They form the mainstay of treatment for leukemias (cytarabine)1 and they are frontline chemotherapy for many solid tumors such as pancreatic, colorectal, non-small cell lung and breast cancer (fluorouracil,2 gemcitabine).3 They were the first drugs shown to be effective for therapy of AIDS (azidothymidine)4 where they are an essential component of the life-prolonging multi-drug cocktails. Nucleoside analogs (acyclovir 1,5 ganciclovir 26) use to treat herpes simplex virus infections.

Present Work:
	This thesis aims at preparation of novel nucleoside compounds with possible potential as therapeutic agents. In the present work we describe the synthesis of novel (β-D-lactopyranosyloxy)methyl nucleosides starting from acetyloxymethyl β–D-lactopyranoside (6). 6 was elegantly prepared7 from β–D-lactose octaacetate (3). Acetyl lactose 3 on reaction with propargyl alcohol in the presence of BF3.Et2O in chloroform at room temperature gave 2-propargyl hepta-O-acetyl lactose (4) which on further reaction with a catalytic amount of Hg(OCOCF3)2 in acetone:H2O (2:1) at room temperature gave the keto derivative 5. Baeyer-Villiger oxidation of 5 with m-CPBA in chloroform gave 1-[(2,2’,3,3’,4’,6,6’-hepta-O-acetyl-β-D-lactopyranosyloxy)methyl]acetate (6).
	Compound 6 was characterised by 1H NMR spectrum from the appearance of seven acetyl groups as seven singlets between δ1.90-2.10. One of the anomeric protons H-1” appeared between δ 4.45-4.55 (merged) along with H-6’a proton. The characteristic oxymethylene protons appeared between δ 5.02-5.20 (2H, AB type quartet, Jgem = 7.8 Hz). 

	Compound 6 is the basic unit on which coupling reactions are performed with silylated pyrimidine and purine bases and trimethylsilyltrifluoromethane sulfonate (TMSOTf) (1.5-2.5 eq.) as Lewis acid activator in CH2Cl2 or CHCl3.
	Typical coupling reaction8 involved the use of bis(trimethylsilyl)uracil (7), bis(trimethylsilyl)thymine (8), N4-benzoyl-bis(trimethylsilyl)cytosine (9), N6-benzoyl- bis(trimethylsilyl)adenine (10) and N2-acetyl-tris(trimethylsilyl)guanine (11). The reaction was performed with silylated bases 7-11 respectively in dry CH2Cl2 or CHCl3 in the presence of TMSOTf at reflux temperature to isolate after work up 1-[(2’,2”,3’,3”,4”,6’,6”-hepta-O-acetyl-β-D-lactopyranosyloxy)methyl]uracil (12), 1-[(2’,2”,3’,3”,4”,6’,6”-hepta-O-acetyl-β-D-lactopyranosyloxy)methyl]thymine  (13),   N4-

Benzoyl-1-[(2’,2”,3’,3”,4”,6’,6”-hepta-O-acetyl-β-D-lactopyranosyloxy)methyl]cytosine (14), N6-Benzoyl-9-[(2’,2”,3’,3”,4”,6’,6”-hepta-O-acetyl-β-D-lactopyranosyloxy)methyl]-adenine (15), N2-Acetyl-9-[(2’,2”,3’,3”,4”,6’,6”-hepta-O-acetyl-β-D-lactopyranosyloxy)-methyl]guanine (16) and N2-Acetyl-7-[(2’,2”,3’,3”,4”,6’,6”-hepta-O-acetyl-β-D-lactopyranosyloxy)methyl]guanine (17) in 40-70% yield. Compounds 12, 13, 14, 15, 16 and 17 were deacylated with a cat. amount of NaOMe/MeOH to obtain β–D-lactopyranosyloxy methyl pyrimidines (18, 19 and 20) (Scheme 2) and purines (21) (Scheme 3), 22 and 23 (Scheme 4) in 82-98% yield.
	Compound 18 [MP 162-164 (dec.); m/z 467 (M++1)] was characterized by 1H NMR (200 MHz, D2O) from the appearance of two oxymethyl protons δ 5.18 and δ 5.38 as AB type doublets (Jgem = 11.9 Hz). H-1’ appeared as a doublet at δ 4.50 (J1’,2’ = 7.9 Hz) indicative of β–configuration of the nucleoside 18. H-5 and H-6 protons of uracil resonated at δ 5.70 and δ 7.48 as doublets (J = 7.4 Hz). The 13C NMR of 18 showed the oxymethyl carbon at δ 77.8, anomeric carbons C-1’ and C-1” at δ 101.6 and δ 102.0 respectively. C-5 and C-6 carbons of uracil resonated at δ 102.7 and δ 146.1 respectively. Compound 18 exhibited specific rotation of [α]D +2.2 (c 0.20, H2O) and the data is in complete agreement with the structure.
	The oxymethyl thymine 19 [MP 178-1800C (dec.); m/z 503 (M++Na) was characterized by 1H NMR (200 MHz, DMSO-d6) from the appearance of two oxymethyl protons at δ 5.12 and δ 5.28 as AB type doublets (Jgem = 9.2 Hz). The anomeric proton  H-1’ appeared as a doublet δ 4.40 (J1’,2’ = 7.8 Hz) indicative of β–configuration. The 5-CH3 and H-6 proton of thymine appeared at δ 1.75 and δ 7.60 as singlets. 19 was also characterised by 13C NMR from the appearance of oxymethyl carbon at δ 80.20 and the two anomeric carbons C-1’ and C-1” at δ 101.76 and δ 103.70 respectively. The methyl carbon of thymine resonated at δ 11.8. Compound 19 exhibited a specific optical rotation of [α]D +45.3 (c 0.20, H2O).
	The cytosine derivative 20 [MP 142-1440C (dec.); m/z 466 (M++1) was characterised by 1H NMR from the appearance of oxymethyl protons at δ 5.22 and δ 5.42 (2H, AB type quartet, Jgem = 7.7 Hz). The anomeric proton H-1’ appeared at δ 4.42 (J1’,2’ = 9.8 Hz). H-5 and H-6 protons of cytosine resonated at δ 6.10 (J = 6.1 Hz) and δ 8.0 as two doublets. Compound 20 was further characterised by its 13C NMR from the appearance of oxymethyl carbon at δ 80.2 and the two anomeric carbons C-1’ and C-1” resonated at δ 103.8 and δ 102.2 respectively. C-5 and C-6 cabrons of cytosine resonated at δ 102.2 and δ 148.8. Compound 20 exhibited optical rotation of [α]D +52.4 (c 0.20, H2O).
	The oxymethyl adenine derivative 21 [MP 252-2530C (dec.); m/z 490 (M++1)] was characterised by 1H NMR (200 MHz, D2O) from the appearance of oxymethylene protons (2H) between δ 5.70-5.98 as AB type doublets (Jgem = 7.9 Hz). Anomeric protons H-1’ appeared at δ 4.50 (J1’,2’ = 7.1 Hz) and H-1” resonated at δ 4.30 (J1”,2” = 6.8 Hz) as a doublets. H-2 and H-8 protons of adenine resonated at δ 8.10 and δ 8.25 as singlets respectively. 21 was further characterised from 13C NMR from the appearance of  oxyme-

thyl carbon at δ 78.2. The two anomeric carbons C-1’ and C-1” resonated at δ 103.4 and δ 100.4. C-2 and C-8 carbons of adenine resonated at δ 153.2 and δ 146.8 respectively. Compound 21 exhibited the optical rotation of [α]D –49.40 (c 0.20, H2O).
Characterisation of N3 and N9 regiomers of 21 by 1H NMR:
	It has been reported in the literature that the difference in chemical shifts for H-2 and H-8 aromatic protons of 3-substituted purines would be Δδ 0.51-0.88 ppm and that of N9-isomer Δδ 0.00-0.30 ppm. In the 1H NMR spectrum of 21, the H-2 and H-8 protons resonated at δ 8.10 and δ 8.25 respectively, thereby exhibiting a difference of Δδ 0.15 ppm in chemical shift indicating it to be N9-isomer.
	Oxymethyl guanine derivative 22 [MP 225-2260C (dec.); m/z 506 (M++1)] by 1H NMR spectrum from the appearance of H-1’ proton at δ 4.60 (J1’,2’ = 7.8 Hz) as a doublet. 
The characteristic oxymethylene protons appeared at δ 5.55 and δ 5.70 as AB type doublets (Jgem = 6.9 Hz). H-8 proton of guanine appeared as a broad signal at δ 7.95. Compound 22 was further characterised by 13C NMR from the appearance of two anomeric carbons C-1’ and C-1” at δ 103.30 and δ 101.98 respectively. C-2 and C-6 carbons of guanine resonated at δ 154.6 and δ 159.30 respectively. Compound 21 exhibited specific rotation of [α]D –13.20 (c 0.10, H2O).
	The oxymethyl guanine derivative 23 [MP 278-2800C (dec.); m/z 506 (M++1)] was characterised by 1H NMR spectra (200 MHz, D2O) from the appearance of H-1’ proton at δ 4.52 (J1’,2’ = 7.6 Hz). The characteristic oxymethylene protons appeared at δ 5.75 and δ 5.85 as AB type doublets (Jgem = 8.7 Hz), H-8 proton of guanine resonated at δ 8.05 as a singlet. 13C NMR showed characteristic appearance of two anomeric carbons C-1’ and  C-1” at δ 104.20 and δ 101.70. C-4, C-5 and C-8 carbons of guanine resonated at

 δ 160.1, 108.1 and δ 144.7 respectively. Compound 22 exhibited a specific rotaiton  of [α]D –54.3 (c 0.20, H2O) (Scheme 4).
Characterization of N7 and N9 isomers by 1H NMR data:
	It has been reported in the literature that N7 and N9 isomers of guanine should be distinguished from 1H NMR spectra by looking at shift of H-8 proton. In case N7 isomer the H-8 proton appears downfield compared to N9 isomer (0.2-0.8).
	In case of 22, the H-8 proton resonated at δ 7.95 as a broad singlet and in case of 23, H-8 proton resonated at δ 8.05. Thus 22 was characterized as N9 isomer and that of 23 as N7 isomer.
Section B :	Synthesis of novel β–D-maltopyranosyloxy methyl pyrimidines and purines
	In the earlier section the synthesis of β–D-lactopyranosyl oxymethyl nucleosides were described. In order to give generality to the reaction described, we initiated our studies on the use of β–D-maltopyranosyl substrate. The key substrate required for coupling acetoxymethoxy -β-D-maltopyranoside (24) was synthesized from the known  β-D-maltose-octaacetate (25). Compound 24 was reacted with propargyl alcohol, BF3.Et2O 

in CH2Cl2 at room temperature to isolate first the propynyl pyranoside 25, which on further reaction with a catalytic amount of Hg(OCOCF3)2 in acetone:H2O (2:1) at room temperature give the keto derivative 26. Baeyer-Villiger oxidation of the keto derivative 26 with m-CPBA give 1-[(2,2’,3,3’,4’,6,6’-hepta-O-acetyl-β-D--maltopyranosyl oxy)methyl]acetate (27) MP 1430C. Compound 27 was characterised by 1H NMR analogous to compound 6 of D-lactose series (Scheme 1).
	Coupling reaction of 27 with bis(trimethylsilyl)uracil (7), bis(trimethyl-silyl)thymine (8), N4-benzoyl-bis(trimethylsilyl)cytosine (9), N6-benzoyl-bis(trimethyl-silyl)-adenine (10) and N2-acetyl-tris(trimethylsilyl)guanine (11) in dry CH2Cl2 or CHCl3 by the addition of TMSOTf (1.5-2.5 eq.)  and stirred at reflux temperature (6-24 h) to isolate after work up 1-[(2’,2”,3’,3”,4”,6’,6”-hepta-O-acetyl-β-D-maltopyranosyloxy)-methyl]uracil (28), 1-[(2’,2”,3’,3”,4”,6’,6”-hepta-O-acetyl-β-D-maltopyranosyloxy)-methyl]thymine (29), N4-Benzoyl-1-[(2’,2”,3’,3”,4”,6’,6”-hepta-O-acetyl-β-D-maltopyra-nosyloxy)methyl]cytosine (30), N6-Benzoyl-1-[(2’,2”,3’,3”,4”,6’,6”-hepta-O-acetyl-β-D-maltopyranosyloxy)methyl]adenine (31), N2-Acetyl-9-[(2’,2”,3’,3”,4”,6’,6”-hepta-O-acetyl-β-D-maltopyranosyloxy)methyl]guaine (32) and N2-Acetyl-9-[(2’,2”,3’,3”,4”, 6’,6”-hepta-O-acetyl-β-D-maltopyranosyloxy)methyl]guanine (33) in 20-75% yield (Scheme 6).

	Compound 28, 29, 30, 31, 32 and 33 were characterised by 1H NMR spectra analogous to the compounds 12, 13, 14, 15, 16 and 17.
	Acetylated oxymethyl derivatives 28, 29, 30, 31, 32 and 33 on hydrolysis using cat. NaOMe/MeOH gave corresponding oxymethyl pyrimidines (34, 35 and 36) (Scheme 6) and purines [37 (Scheme 7), 38 and 39 (Scheme 8)] respectively in 85 to 98% yields.
	Compound 34 [MP 157-1580C (dec.); m/z 467 (M++Na)] was characterised by 1H NMR (200 MHz, D2O) from the appearance of oxymethyl protons (2H) between δ 5.20-5.40 (AB type quartet; Jgem = 9.8 Hz) along with H-1” proton. The other anomeric proton H-1’ appeared at δ 4.50 (J1’,2’ = 7.8 Hz) as a doublet. H-5 and H-6 protons of uracil appeared at δ 5.70 and δ 7.58 (J5,6 = 8.2 Hz) respectively. Compound 34 was further characterised by 13C NMR spectrum from the appearance of oxymethyl carbon at δ 76.9, anomeric carbon C-1” appeared at δ 99.6 and carbon C-1’ at δ 101.9. C-5 and C-6 carbons of uracil appeared at δ 102.3 and δ 146.4 respectively. Compound 34 exhibited specific rotation of [α]D +64.6 (c 0.20, H2O) and the data is in complete agreement with the structure of nucleoside 34.
	Compound 35 [MP 2470C (dec.); m/z 503 (M++Na)] was characterised by 1H NMR (200 MHz, D2O) from the appearance of anomeric proton H-1’ at δ 4.62 (J1’,2’ = 7.9 Hz) as a doublet. One of the two oxymethyl protons appeared at δ 5.30 (Jgem = 9.8 Hz) as AB type doublet. The other oxymethyl proton appeared at δ 5.50 (merged with H-1” proton). The methyl protons  of thymine appeared at δ 1.82 and H-6 proton at δ 7.58 as a singlet. Compound 35 was further characterised by 13C NMR spectrum from the appearance of characteristic oxymethyl cabron at δ 77.10. The two anomeric cabrons C-1’ and C-1” resonated at δ 102.2 and δ 100.0 respectively. The methyl group of thymine resonated at δ 11.7. Compound 35 exhibited optical rotation of [α]D +73.2 (c 0.20, H2O).
	The oxymethyl cytosine 36 [MP 147-1490C (dec); m/z 466 (M++1)] was characterised by 1H NMR (200 MHz, D2O) from the appearance of oxymethyl protons (2H) at δ 5.50 and δ 5.38 (merged with H-1” proton). The anomeric proton H-1’ appeared at δ 4.65 (J1’,2’ = 7.8 Hz) as a doublet indicative of β-configuration. Compound 36 was further characterised 13C NMR spectrum from the appearance of oxymethyl carbon at δ 77.0. The two anomeric carbon C-1’ and C-1” resonated at δ 99.8 and δ 101.5 respectively. C-4 and C-6 cabrons of cytosine resonated at δ 166.5 and δ 146.5. 36 exhibited optical rotation of [α]D +89.2 (c 0.20, H2O).
	Adenine derivative 37 [MP 2100C (dec.); m/z 490 (M++1)] was characterised by 1H NMR (300 MHz, D2O) from the appearance of two oxymethyl protons δ 5.78 and δ 5.90 (AB type quartet, Jgem = 11.2 Hz). The anomeric proton H-1’ appeared at δ 4.45 (J1’,2’ = 7.8 Hz)  as a  doublet.   Compound 37 was  characterised  by  13C NMR  from  the 

appearance of oxymethyl carbon at δ 81.2. The anomeric carbons C-1’ and C-1” resonated at δ 102.5 and δ 101.5 respectively. C-2 and C-8 carbons of adenine resonated at δ 154.8 and δ 148.0. Compound 37 exhibited a optical rotation of [α]D –10.3 (c 0.20, H2O).
Characterisation of N3 and N9 regiomers of 37 by 1H NMR:
	Regiochemistry of compound 37 was assigned analogous to the corresponding nucleoside of lactose  (Section A, Chapter 1, Scheme 3). A chemical shift difference of Δδ 0.13 ppm between H-2 and H-8 was observed in 1H NMR spectrum of 37, the small difference is characteristic of N9 regioisomer. Compound 37 was thus characterised as N9-isomer.
	The 9-isomer of guanine derivative 38 [MP 179-1810C (dec.); m/z 504 (M+-1)] was characterised by 1H NMR (200 MHz, DMSO-d6) from the appearance of oxymethyl 
protons at δ 5.45 and δ 5.55 (2H, AB type quartet, Jgem = 10.4 Hz). The anomeric proton H-1’ appeared at δ 4.42 (J1’,2’ = 7.0 Hz) as a doublet. Compound 38 was further characterised by 13C NMR spectrum from the appearance of oxymethyl carbon at δ 79.2. The two anomeric carbons C-1’ and C-1” appeared at δ 101.0 and δ 100.6 respectively. C-8 carbon of guanine resonated at δ 137.6. Compound 38 exhibited a specific rotation of [α]D + 3.2 (c 0.10, H2O) and the data is in complete agreement with the structure.
	Compound 39 [MP 224-2260C (dec.); m/z 504 (M+-1)] was characterised by 1H NMR (300 MHz, DMSO-d6) from the appearance oxymethyl protons at δ 5.70 and δ 5.82 (2H, AB type quartet, Jgem = 9.7 Hz). The anomeric proton H-1’ appeared at δ 4.58 (J1’,2’ = 7.8 Hz) as a doublet. The characteristic H-8 proton of guanine appeared at δ 8.10 as a singlet. Compound 39 was further characterised by 13C NMR from the appearance of oxymethyl carbon at δ 79.0. The anomeric cabrons C-1’ and C-1” at δ 101.2 and δ 100.2 respectively. C-8 cabron of guanine resonated at δ 107.7 and the above data is in complete agreement with the structure.

	Regiochemistry of the compound 38 and 39 was established analogous to the nucleosides of lactose 22 and 23 (Section A, Chapter 1, Scheme 4). In case of compound 34 the appearance of proton H-8 at δ 7.80 as a broad singlet (1H NMR) and C-5 at δ 116.2 (13C NMR) was characteristic of N9-regioisomer. In case of compound 35 the appearance of H-8 at δ 8.10 as singlet (1H NMR) and C-5 at δ 107.7 (13C NMR) was characteristic of N7-regioisomer.


CHAPTER II :	Resolution of 1-arylalkylamines with hydrogen phthalate esters of β-D-glucofuranose bearing 1,2:5,6-di-O-isopropylidene 1,2:5,6-di-O-cyclohexylidene and 1,2-O-cyclohexylidene-5,6-O-diphenylmethylidene substituents.
	Resolution via diastereomeric salt formation is one of the most practical methods for obtaining enantiopure compounds.9 Despite its importance, the method, however, requires a lot of trail-and-error10 experimentation to choose a suitable resolving agent, since chiral descrimination mechanism during resolution is not clear.
Present Work:
	Enantiomerically pure 1-arylalkylamines play an important role in stereoselective organic synthesis. They are used as resolving agents,11,12 chiral auxiliaries13 and building blocks in pharmaceuticals, agrochemicals and in the synthesis of  several interesting natural products.14 Various resolving agents have been used for resolution of 1-arylalkylamines.
	We intended to design new acidic resolving agents from carbohydrates and study the chiral recognition mechanism. Use of carbohydrates for this purpose has the following advantages. i) They are available in various chiral forms ii) they can be derivatized to achieve the required conformational regidity for effective resolution and iii) finally study the recognition phenomena.
	Recently we have developed new acidic resolving agents which are hydrogen phthalates of carbohydrates and demonstrated their efficiency for resolution of several 1-arylalkylamines. We have observed that hydrogen phthalate of 1,2-di-O-isopropylidene-3,6-anhydro-α-D-glucofuranose15 forms diastereomeric salt with (R)-1-arylalkylamines selectively and 6-O-hydrogen phthalate of 1,2:3,4-di-O-isopropylidene-α-D-galactopyranose16 with (S)-1-arylalkylamines respectively from the corresponding racemates  in  good  yield  and  enantiomeric  excess.   Based  on  these  results  it seemed 

worthwhile to gain more information on the mechanism of chiral recognition of the acidic resolving agents. We have selected three acidic resolving agents 43, 44 and 45 which are hydrogen phthalates of glucofuranose each one of them having increasing bulk of substituents on the dioxalane to import conformational rigidity. Accordingly resolving agents 3-(1,2:5,6-di-O-isopropylidene-α-D-glucofuranosyl)hydrogen phthalate (43) 3-(1,2:5,6-di-O-isopropylidene-α-D-glucofuranosyl)hydrogen phthalate (44) and 3-(1,2-di-O-cyclohexylidene-5,6-O-diphenylmethylidene-α-D-glucofuranosyl)hydrogen phthalate (45) were prepared (Scheme 9).
	Reaction of 1,2:5,6-di-O-isopropylidene-α-D-glucofuranose17 (40) (0.30 mol) and phthalic anhydride (0.30 mol) in dry pyridine and 1,2:5,6-di-O-cyclohexylidene-α-D-glucofuranose18 (41) (0.22 mol) with phthalic anhydride (0.22 mol) in Et3N (140 mL) and 1,2-O-cyclohexylidene-5,6-O-diphenylmethylene-α-D-glucofuranose (42) (0.12 mol) with phthalic anhydride (0.12 mol) in Et3N (150 mL) at reflux temperature for 3 h after usual work up gave corresponding hydrogen phthalate derivatives 43 (70%, MP 163-1640C), 44 (93%, MP 57-590C) and 45 (90%, MP 84-860C) as crystalline solids. Compounds 38, 39 and 40 were characterised by 1H NMR spectra from the appearance of anomeric proton H-1 at δ 5.90 (J = 3.2 Hz), δ 5.90 (J = 3.4 Hz) and δ 5.85 (d, J = 2.7 Hz) respectively.

	Compound 43 and 44 were treated with several (R,S)-1-arylalkylamines (resolving agent 43 with 46-57 and 44 with 46-51, 53-57) (Scheme 10) by briefly boiling in methanol (2 mL/g) or 2-propanol (5 mL/g) and allowing to slowly cool (6-24 h) to –100C. The precipitates formed were filtered, washed with methanol or 2-propanol to obtain 43.(S)-46-55 and 44.(S)-46-51, 53-54 diastereomeric salts and decomposed to isolate the corresponding (S)-1-arylalkylamines (46-55) in good yield (80.2-92%) and enantiomeric excess (86-100% e.e.) (Table 1), 91.4-97.3% e.e. (Table 2). The filtrates were concentrated and decomposed to obtain the corresponding (R)-1-arylalkylamines (46-55) in 80.2-89.2% e.e. (Table 1, entires i-ix) and 80.3-89.3% respectively Table 2, entires i-viii). It was observed that the glucofuranose 44 with bulky cyclohexylidene substituents exhibited marginally higher resolving efficiency for p-substituted phenylethylamines. The corresponding glucofuranose derivative 43 with less bulkier isopropylidene substituents.
	We observed that (R,S)-2-aminopropiophenone (58) was resolved by 43 and 44 with poor e.e (6-12%) (Table 1; 2, entries xiii, xii).
	Resolving efficiency of resolving agent 45 bearing diphenyl groups on the 1,3-dioxalane was studied with selected number of o- p- and m-substituted 1-arylalkylamines 48, 51, 53 and 55 as well as 46. It was observed that resolving efficiency of 45 was very poor 5-9% and in all experiments they failed form precipitates.
	In summary we have found that hydrogen phthalates of glucofuranose derivatives were suitable resolving agents for 1-arylalkylamines.
















































CHAPTER III	:	Synthesis and resolution of (R,S)-4-methoxy ampheta-
mine, an intermediate for the synthesis of (R,R)-Formoterol
Synthesis of 4-methoxy-amphetamine:
	β-Arylethylamine functionality is essential to many amphetamine drugs that offer high selectivity for β2-adrenoceptors.19   A variety of  β2-adrenoceptor agonists have been 

prepared for treatment of asthma and chronic bronchitis. Among them formoterol offers high selectivity for β2-adrenoceptors and has excellent safety, tolerance profile. Synthesis of 59 required preparation of 2-amino-1-(4-methoxyphenyl)-propane (60) by a process which is amenable to scaleup, avoids use of hazardous reagents, elevated temperature and pressure.
Present Work:
	Here we describe a simple laboratory method for the preparation of amine 55. Horner-Wadsworth-Emmons reaction of 61 with ethyl-(2-methoxyphosphenyl)-2-propanoate (62)20 (1.1 mol eq.) and NaOtBu (1.5 mol eq.) in toluene at room temperature for 15 min. to afford the α/β–unsaturated ester 63. 63 was characterized by 1H NMR (200 MHz, CDCl3) from the appearance of H-3 proton at δ 7.62 as a singlet. The ester 63 on catalytic hydrogenation (1 atm with 10% Pd/C) in MeOH for 4 h gave the saturated ester 64.

	The saturated ester 64 was characterised by 1H NMR (200 MHz, CDCl3) from the appearance of benzylic hydrogens between δ 2.50-2.75 (m, 2H, C6H5-CH2) as a multiplet.The proton adjacent into ester appeared between δ 2.80-3.05 as a multiplet [Mass (EI-MS): m/z 222 (M+)]. Hydrolysis of ester 64 with aq. NaOH (20%) and a catalytic amount of cetrimide at reflux temperature for 5 h gave the acid derivative 65. 65 was characterised by 1H NMR (200 MHz, CDCl3) from the appearance of H-2 at δ 2.90-3.10 as a multiplet. The methyl group appeared at δ 1.18 (J = 5.0 Hz) as a doublet, benzylic protons at δ 2.62 (1H, J2,3 = 7.5 Hz) and δ 2.88 (1H) as two double doublets, the methoxy group at δ 3.78 as a singlet [IR (Neat): νmax 3388, 3200, 1662 and 1459 cm-1; mass (EI-MS): m/z 193 (M+)]. Compound 65 was transformed to the corresponding amide 66 MP 119-1210C by reaction with SOCl2 followed by quenching with methanolic ammonia solution at –50C.  Compound 66 was characterised by 1H NMR (200 MHz, CDCl3) from the appearance of benzylic protons at δ 2.62 (1H, J2,3 = 7.0 Hz) and δ 2.88 (1H) as two double doublets, the methoxyl group at δ 3.78 as a singlet. Hoffman degradation of amide 65 by reaction with NaOBr at 700C for 2 h gave amine 60 in 67% overall yield from p-anisaldehyde and that exhibited comparable 1H NMR spectra with that reported in literature.20
	In conclusion a simple, high yielding laboratory method for the preparation of amphetamine derivative has been achieved starting from p-anisaldehyde.
Resolution of (R,S)-p-methoxy amphetamine:
	In this method developed by us amphetamine (R,S)-60 was reacted with chiral lactone 6721 to form a pair of diastereomeric amides (R)-68 and (S)-68.
	Diastereomers [(R)-68 and (S)-68] thus formed were separated by HPLC (reverse phase) [(S)-68 had retention time 18.48 min. and (R)-68 had 20.549 min. Ratio of (S)-68 : (R)-68, 1:1.23 (column : ODS, eluant : 20% CH3CN + 40% MeOH + 40% H2O). (S)-68 and (R)-68 were characterized by 1H NMR (200 MHz, CDCl3) from the appearance of methyl group at δ 1.10 (d, J = 5.2 Hz), benzylic protons of (S)-68 and (R)-68 at δ 2.60-2.80 (2H) as a multiplet. The H-2 proton appeared between δ 3.70-3.90 (1H) for (S)-68 and δ 3.62-3.80 for (R)-68. H-2 proton of sugar part α– to amide group appeared at δ 4.50 (d, J = 6.4 Hz) for both isomers [(S)-68, [α]D –9.4 (c 0.50, MeOH); (R)-68, [α]D –12.6 (c 0.50, MeOH)].

	(S)-68 MP 124-1260C and (R)-68 MP 128-1300C were individualy hydrolysed with 10% aq. KOH to isolate (S)-60 {[α]D +24.2 (c 0.50, MeOH, 82% e.e. lit.23 [α]D +30.2 (c 1.00, MeOH)} and (R)-60 {[α]D –22.1 (c 0.50, MeOH, 75% e.e. lit.23 [α]D +29.5 (c 1.00, MeOH)}  
	Thus a new method to separate biologically useful amphetamine enantiomers was successfully developed.  
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